RNAble Email Formats

Biotechnology Research • Nes Ziona, Center District, Israel • 1-10 Employees

RNAble Email Formats

RNAble uses 1 email format. The most common is {first name} (e.g., john@futurx.co.il), used 100% of the time.

Format	Example	Percentage
{first name}	john@futurx.co.il	100%

Key Contact at RNAble

Amir Mor

Chief Scientific Officer And Co-Founder

Company overview

Headquarters	Ilan Ramon Street 2, 3rd floor, Ness Ziona, 7404905, IL
Phone number	+97289553100
Website	futurx.co.il
Keywords	RNA, Cancer, Small Molecule
Founded	2021
Employees	1-10
Socials

About RNAble

RNAble is a preclinical biotechnology company developing a potent small-molecule inhibitor targeting FTO, a key driver of oncogenic RNA biology. Mechanistic studies have led to the identification of a specific biomarker that predicts pan-cancer sensitivity to the inhibitor across both hematological and solid malignancies. Key highlights of RNAble's lead candidate: • Demonstrates strong in vivo efficacy and superior antitumor activity compared to standard-of-care therapies in AML models. • Shows promising efficacy in preclinical models of biomarker-selected solid tumors. • Features a novel, validated mechanism of action that induces cancer cell death via RNA-mediated mitotic catastrophe followed by apoptosis, with potential to overcome resistance to current therapies. • Exhibits strong oral bioavailability and a favorable safety profile. • Expected IND submission in 2026.